Preventative and corrective maintenance service contract for an illumina miseq DNA sequencer (serial #: 362) and a BD LSR fortessa fluorescence-activated cell sorting (FACS) system (customer…
Ended Awarded Last action
- Contract number
- 75F40122F80179
- Awardee
-
The Remi Group LLC UEI X458FNVQ1YX9
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $44,849
Award facts
- Opportunity
-
- GSAFDARFQ75F40122Q125 Solicitation number
- Contract value 100% obligated
- $44,849.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Charlotte, NC 28277, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$5,338 | |
| Terminate for Convenience | $0 | |
| Exercise an Option | $11,328 | |
| Exercise an Option | $10,998 | |
| Original award | $27,861 |
About this award
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to The Remi Group LLC, a for-profit Subchapter S corporation based in Charlotte, North Carolina. The contract provides preventative and corrective maintenance services for an Illumina MiSeq DNA sequencer and a BD LSR Fortessa fluorescence-activated cell sorting (FACS) system. The contract has a ceiling value of $44,849.14 and a period of performance through March 13, 2025. This award is made under the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract. The Remi Group LLC is an experienced provider of maintenance, repair, and support services for scientific, medical, and laboratory equipment across various federal agencies, including the FDA, National Institutes of Health, and Centers for Disease Control and Prevention.
Description
Preventative and corrective maintenance service contract for an illumina miseq DNA sequencer (serial #: 362) and a BD LSR fortessa fluorescence-activated cell sorting (FACS) system (customer material#: 647794L5, serial#: H647794L5014), base + 4 years
Quick answers
Who was awarded contract 75F40122F80179?
75F40122F80179 was awarded to The Remi Group LLC by Food and Drug Administration (Department of Health and Human Services) on September 1, 2022.
How much is contract 75F40122F80179 worth?
The government has obligated $44,849 on 75F40122F80179.
Is contract 75F40122F80179 an order under another contract?
Yes. 75F40122F80179 is a delivery order under GS21F0093V, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40122F80179 competed?
The extent of competition for 75F40122F80179 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award